Autonomic Tech Announces Expanded Indication In Europe (CE Mark) For Disabling Migraine With Pulsante SPG Microstimulator System Post author:Sam Post published:March 9, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like IRadimed Corporation Poised For Market Domination February 13, 2017 Acucela Granted New Patent Covering Method Of Use For Emixustat Hydrochloride September 10, 2017 Aclaris To Host R&D And Investor Event On October 4, 2017 In New York September 19, 2017